



To migrate and to invade a cell needs to detach 
from its neighbors, i.e. adjacent cells in an epi-
thelium, to extend lamellipodia and filopodia 
from the leading edge and to create new dy-
namic adhesions, which form and rapidly disas-
semble at the base of protrusions [1, 2]. Cell 
invasion also requires the release or activation 
of proteases that degrade the extracellular ma-
trix (ECM) and allows cells to sort out from the 
basal lamina invading surrounding tissues [3]. 
Under physiological conditions cell motility and 
invasion are tightly controlled by a complex in-
terplay among cell-cell, cell matrix and growth 
factors receptors resulting in the maintenance 
of the architectural integrity of human tissues. 
This subtle regulation is lost in human tumours 
leading to uncontrolled dissemination of cancer 
cells into the body [4-7]. At least three major 
class of membrane proteins are involved in 
these events, namely, the integrin receptors, 
the Receptor tyrosine kinases (RPTKs), and the 
E-cadherin.   
 
Integrins are cell surface heterodimeric recep-
tors for the ECM formed by the non covalent 
association of alpha and beta subunits [8]. In-
tegrins specifically localize to focal adhesions, 
which are sites of close apposition with the ECM 
where actin filaments are anchored to the 
plasma membrane. Integrins are catalytically 
inactive and translate positional cues into bio-
chemical signals by direct and/or functional 
association with intracellular adaptors or growth 
factor and cytokine receptors, thus regulating 
integrin ability to transduce signals inside the 
cells, the so called “outside-in signalling” [9]. 
Integrin adaptor proteins, such as p130Cas, 
serve as multi-functional scaffolding proteins, 
leading to protein-protein interactions by the 
recruitment of kinases, phophatases and their 
substrates together [9]. A growing body of evi-
dence shows that integrins, RPTKs and cytokine 
receptors have no longer to be considered as 
individual receptors, but rather as joint modules 
in which attachment to the matrix confers posi-
tional control to respond to soluble growth fac-
tors [6, 10-13]. In the case of the EGF receptor 
(EGFR), beta1 integrin is both sufficient to par-
tially activate the receptor itself and required for 
the full activation of the EGFR in response to 
EGF [14]. This EGFR trans-activation accounts 
for a specific repertoire of mechanisms, namely 
cell survival and actin cytoskeleton organization 
involved in cell migration. 
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The cell-cell adhesion receptor E-cadherin is the 
major membrane protein involved in binding 
between neighbouring cells in adherens junc-
tions. As a practical consequence of its adhe-
sive functions, E-cadherin has also been shown 
to prevent EGFR activation and downstream 
signalling, leading to negative regulation of pro-
liferation [15-18]. E-cadherin is frequently down-
regulated or lost in epithelial tumours [19-21]. 
In this review we will focus on p140Cap and 
p130Cas as major regulators of the complex 
cross-talk among integrin, E-cadherin and 
RPTKs signalling. Both p140Cap and p130Cas 
regulate cell growth and cell motility, while 
p130Cas can also sustain cell survival [9]. Ow-
ing to their modular structure, both proteins can 
undergo tyrosine phosphorylation and associa-
tion with effector proteins, leading to the assem-
Figure 1. p130Cas and p140Cap signalling involved in migration and invasion. Upon extracellular matrix binding or 
growth factors stimulation, integrins and Receptor Protein Tyrosine Kinases (RPTK) represent the major upstream 
regulators of p130Cas and p140Cap, mainly through the regulation of Src kinase activity. Once tyrosine phosphory-
lated by Src, p130Cas recruits proteins that activate downstream pathways, resulting in actin cytoskeleton re-
organization, increased cell motility and migration. p130Cas by acting on metalloproteinases (MMPs) promoter is 
also required for the invasive program. Upon cell matrix adhesion or mitogen stimulus, p140Cap inhibits Src kinase 
activity and p130Cas tyrosine phosphorylation and p130Cas/Crk complex formation. As a consequence, the effect of 
p130Cas on actin cytoskeleton re-organization is impaired and cell migration and invasion are inhibited. Moreover, by 
inactivating Src, p140Cap also regulates the epidermal growth factor receptor (EGFR) pathway through E-cadherin-
dependent inactivation of EGFR signalling. p140Cap by interacting  with E-cadherin and EGFR at the cell membrane, 
immobilizes E-Cadherin at the cell membrane thus preventing cell migration and invasion. 
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bly of molecular platforms that regulate a vari-
ety of signalling events (Figure 1). 
 
Structure and major interactors of p140Cap  
 
The human p140Cap (Cas-associated protein) is 
coded by the Srcin1 gene, which is conserved in 
human, mouse, rat, dog, cow, and zebrafish and 
in humans is localized on Chromosome 
17q21.1.  
 
The p140Cap protein was originally identified as 
SNIP (SNAP-25b-Interacting Protein) in the rat 
brain. In this tissue p140Cap/SNIP is involved 
in the regulation of neurosecretion, likely by 
anchoring SNAP-25 to the membrane cytoskele-
ton [22]. p140Cap is a multi-site docking      
protein, composed by a putative N-terminal 
myrystylation site, a tyrosine-rich domain, two 
proline-rich regions, a coil-coiled domain, two 
charged amino acid rich regions and a putative 
actin-binding site (Figure 2) [22, 23]. p140Cap 
is mainly expressed in brain, testis and epithe-
lial-rich tissues such as mammary gland, lung, 
colon and kidney [22-24]. The presence of 
many conserved sequence motifs that can un-
dergo extensive post-translational modification, 
such as tyrosine and serine phosphorylation, 
suggests that p140Cap can elicit protein–
protein interactions, leading to the formation of 
multi-protein complexes. Indeed p140Cap is 
tyrosine phosphorylated in epithelial cells upon 
integrin-mediated adhesion and EGF receptor 
activation [23] and it has been shown to associ-
ate with several proteins. In normal epithelial 
cells, p140Cap and p130Cas are associated in 
a indirect manner and this association occurs 
through the last 217 amino acids of p140Cap 
and the amino acids 544-678 of p130Cas. The 
same C-terminal region of p140Cap has been 
described to bind directly to the SH3 domain of 
the Src kinase in breast tumor MCF7 cells [25], 
suggesting that Src kinase may represent the 
molecular bridge between p140Cap and 
p130Cas. Moreover in MCF7 cells by Far West-
ern Blotting p140Cap has been shown to bind 
directly the kinase C-terminal Src kinase (Csk), a 
potent negative regulator of Src. The domains 
involved in the interaction of Csk with p140Cap 
remain to be elucidated. 
 
By two hybrid screening in human brain, the C-
Figure 2. p140Cap and p130Cas structure. A) p130Cas consists of an N-terminal SH3 domain, a substrate domain 
(SD), a serine rich region (SRR), and a C-terminal domain (CT). The main interactors are indicated. In particular, many 
proteins associate to the N-terminal domain and the Src family kinases (SFKs) bind the CT domain. The 15 YxxP mo-
tifs are phosphorylated by Src family kinases to mediate Crk binding. B) p140Cap consists of an N-terminal tyrosine–
rich region (Tyr-rich), an actin binding domain (ABD), a proline rich domain (Pro1), a coil-coiled region (C1-C2), two 
domains rich in charged amino acids (CH1, CH2) and a C-terminal proline rich domain (Pro2). Src, p130Cas, EB3 and 
Vinexin bind to the Pro2 domain of p140Cap. The binding regions of Cortactin and Csk have yet to be defined.  
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terminal domain of p140Cap has also been 
found to associate with Vinexin SH3 domain. 
Vinexin belongs to a family composed of vinexin, 
c-Cbl associated protein/ponsin, and Arg-
binding protein 2. This association has been 
confirmed by immunoprecipitation in epithelial 
cells and rat brain. In non-neuronal cells, Vin-
exin is localized at focal adhesions where it is 
involved in growth factor- and integrin-mediated 
signal transduction, cytoskeletal organization, 
cell spreading, motility, and growth [26]. The 
Vinexin-p140Cap interaction might affect sub-
cellular localization of these proteins and be 
involved in the formation and/or maintenance 
of synapses [24]. 
 
In the brain, p140Cap also directly associates 
with all members of the microtubule (MT) plus-
end tracking protein EB family, through a short 
92 amino acid C-terminal region (aa 1124–
1216), likely via a positively charged S/P-rich 
region [25]. Finally, p140Cap has also been 
shown to pull-down with Cortactin, a Src kinase 
substrate and F-actin binding protein, capable 
of promoting actin stability and nucleation in 
non-neuronal cells [27], and dendritic spines of 
cultured hippocampal neurons [28]. In hippo-
campal neurons, depletion of either EB3 or 
p140Cap causes defective spine morphology, 
indicating that the two proteins are involved in 
stabilization of mature mushroom-like spines. 
The interactions of p140Cap with EB3-positive 
MT plus-end and Cortactin may therefore repre-
sent a link between the local signalling of MTs 
and the actin cytoskeleton within the dendritic 
spines [25].  
 
Overall, the p140Cap binding partners are 
mainly implicated in membrane fusion and actin 
cytoskeleton remodelling. p140Cap association 
to p130Cas, Src, Cortactin and the presence in 
the p140Cap sequence of a putative actin-
binding domain in the p140Cap sequence ho-
mologous to the yeast protein AIP3 [29] suggest 
that p140Cap may also be a potential actin-
binding protein.  
 
p140Cap negatively regulates Src-dependent 
migration and invasion 
 
So far, one of the major functions described for 
the p140Cap is to inhibit the activation of Src 
kinase. The mechanism through which 
p140Cap acts on Src activation has been re-
cently defined. In breast cancer cells, upon cell-
matrix adhesion or EGF stimulation, p140Cap 
activates Csk kinase that by phosphorylating the 
negative regulatory tyrosine on the C-terminal 
Figure 3. p140Cap stabilizes E-Cadherin molecules at the cell membrane. E-cadherin stability and recycling at the cell 
membrane is crucial for cell-contact growth inhibition  and inhibition of cell scatter. Our recent results show that 
p140Cap stabilizes E-cadherin at the cell membrane through the inhibition of Src kinase. p140Cap over-expressing 
(p140-oe) and Ctr breast cancer MCF-7 cells were co-transfected with E-Cadherin-GFP and Csk-RNAi. E-Cadherin dy-
namics were analyzed by fluorescence recovery after photobleaching (FRAP). The Fluorescence recovery curves are 
shown on the left, and the histogram of the % of immobile E-Cadherin fraction on the right (*p<0.05). The data show 
that p140 over-expressing cells have a higher amount of the immobile fraction (35%) compared to control cells 
(20%), confirming that p140Cap stabilizes E-Cadherin molecules at the cell membrane. Moreover, E-cadherin mem-
brane dynamics were restored when Src was rescued by Csk knock-down. siRNA oligos decrease the immobile frac-
tion of p140 over-expressing cells to the level of Ctr cells. The figure is modified from [31]. 
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domain of c-Src induces a conformational 
change in the c-Src structure that prevents its 
activity. Consistently, silencing of p140Cap in-
creases Src activation, leading to a fine tuning 
of integrin and growth factor receptor signalling 
(Figure 1) [30, 31]. As a consequence, in cells 
expressing high levels of p140Cap, upon in-
tegrin-mediated adhesion, the association be-
tween Src and Fak is impaired. p140Cap over-
expression does not modify phosphorylation of 
Fak on autocatalytic tyrosine 397, but rather 
inhibits Src-dependent phosphorylation of Fak 
tyrosine 925. Moreover, elevated p140Cap ex-
pression also impairs integrin-dependent 
p130Cas phosphorylation, leading to inhibition 
of Rac1 [31].  
 
As expected for the major role of Src and down-
stream signalling in actin cytoskeleton dynamics 
and cell migration, high levels of p140Cap im-
pair spreading and extension of lamellipodia 
and filopodia on ECM proteins of breast cancer 
cells. In addition, p140Cap over-expression also 
inhibits migration on fibronectin-coated tran-
swells and invasion in Matrigel. Consistently, 
p140Cap silencing induces an increase in cell 
spreading in the early phases of cell adhesion, a 
fibroblastic-like shape and increased motility 
and invasion. Cells expressing a truncated form 
of p140Cap, lacking the Src-binding domain, 
restores integrin-dependent Src and Rac activa-
tion and are capable of migrating and invading 
properly [31].  
 
In addition, p140Cap specifically interferes with 
invasive and migratory properties of cancer cells 
inhibiting EGFR-dependent cell scatter of breast 
and colon cancer. This occurs by reinforcing E-
cadherin inhibition of EGFR activity in tumor 
cells. Indeed, it has been demonstrated that 
p140Cap plays a crucial role in the regulation of 
E-cadherin-dependent cell-cell adhesion. In par-
ticular, in MCF7 breast cancer cells, p140Cap 
controls cell-cell contact dynamics by increasing 
the amount of immobilized E-cadherin at the 
cell surface (Figure 3), thereby regulating the 
strength of cell-cell adhesion. This mechanism 
depends on Src kinase activity, as shown by the 
recovery of E-cadherin mobility at the cell sur-
face through the expression of a kinase-
defective Csk mutant, or by Csk silencing. In the 
same conditions, EGFR phosphorylation is re-
stored, as well as the ability to scatter in re-
sponse to EGF. Thus p140Cap impairs cancer 
cell scatter through Src inactivation which re-
sults in decreased E-cadherin mobility at the 
cell membrane, thereby affecting EGFR signal-
ling leading to cell motility (Figure 4) [30].  
 
Structure and major interactors of p130Cas  
 
The p130Cas protein is characterized by the 
presence of multiple conserved sequence mo-
tifs and extensive post-translational modifica-
tion, mainly consisting of tyrosine and serine 
phosphorylation. These structural features allow 
the assembly of specific multi-protein com-
plexes that result in the regulation of cell adhe-
sion, migration and survival. In particular, 
p130Cas consists of an N-terminal Src homol-
ogy 3 (SH3) domain, a substrate domain, a ser-
ine rich region, and a C-terminal domain (Figure 
2). The SH3 domain interacts with polyproline-
rich sequences present in several proteins in-
cluding Fak, PYK2/RAFTK, phosphatases like 
PTP-PEST, PTP1B, and effectors as C3G and CIZ 
[32, 33] The substrate domain, characterized by 
a sequence of 15 YxxP motifs, upon Src family 
kinases phosphorylation, is tyrosine phosphory-
lated and exposes additional binding sites for 
SH2 containing proteins such as the Crk adap-
tors [34, 35], while the serine rich region repre-
sents a docking site for other partners such as 
14-3-3 and GRB2. Lastly, the C-terminus con-
tains a polyproline-rich region responsible for 
the binding of the Src family kinase, PI3K, 
BCAR3/AND-34, CHAT-H and ubiquitin ligases 
such as AIP4, APC/C and CDH1, as well as a 
binding site for the adaptor protein p140Cap 
[23, 36, 37]. 
 
p130Cas tyrosine phosphorylation and cell mi-
gration 
 
p130Cas represents a nodal signalling platform 
on which integrin and RPTKs signalling convey. 
Integrins, RPTKs and oestrogen receptor (ER) 
are major upstream regulators of p130Cas, 
mainly through the activation of Src and Fak 
kinases, leading to p130Cas tyrosine phos-
phorylation on the C-terminal binding site 
YDYVHL (Figure 1) [9]. Moreover, physical 
stretching of p130Cas induces a conformational 
change that enables Src-family kinase-
dependent p130Cas tyrosine phosphorylation. 
These findings point out a function for p130Cas 
as a sensor that integrates mechanical forces 
coming from the extracellular environment into 
intracellular signals leading to actin cytoskele-
ton reorganization [38, 39]. 
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The role of p130Cas in cell migration was ini-
tially inferred by studies performed in mouse 
embryo fibroblasts (MEFs) derived from 
p130Cas knock-out mice. p130Cas null MEFs 
show defects in stress fibre formation and cell 
spreading, impaired actin bundling and cell mi-
gration [40], that were restored by full-length 
p130Cas expression. The tyrosine phosphoryla-
tion of the substrate domain of p130Cas pro-
vides binding sites for Crk proteins that in turn 
associates with DOCK180, a guanine nucleotide 
exchange factor that switches the small GTPase 
Rac1 from a GDP-bound inactive to a GTP-
bound active state at lamellipodia and filopodia 
adhesion sites [41, 42]. This drives localized 
Rac activation, membrane ruffling and actin 
cytoskeleton remodelling, focal adhesion turn-
over, pseudopodia formation and extension. In 
addition, ARP2/3 and PAK kinase activation 
enhance cell migration [43].  
 
It has been reported that expression of Bmx/
Etk, a member of the Tec/Btk family of nonre-
ceptor kinases, enhances tyrosine phosphoryla-
tion of p130Cas and the formation of p130Cas/
Crk complex. Moreover, the co-expression of 
Bmx with p130Cas results in an enhanced 
membrane ruffling and haptotactic cell migra-
tion. The expression of a mutant form of 
p130Cas, unable to interact with Crk, inhibits 
Bmx-induced membrane ruffling and cell migra-
tion, indicating that p130Cas and the adaptor 
protein Crk complex formation is instrumental 
for connecting several stimuli to the regulation 
of actin cytoskeleton and cell motility [44]. Un-
coupling of p130Cas/Crk negatively regulates 
cell migration. Indeed, the non-receptor tyrosine 
kinase Abl phosphorylates Crk-II on tyrosine 
221, inducing intramolecular folding that pre-
vents binding of the C-terminal Crk-II SH2 do-
main to the phosphorylated p130Cas substrate 
domain, leading to decreased cell movement 
[45, 46]. 
 
Additional molecules that play important roles in 
modulating tyrosine phosphorylation of 
p130Cas leading to cell migration are the zyxin/
Ajuba family of LIM proteins. These proteins 
bind to actin cytoskeleton and are implicated in 
cell motility. Ajuba allows p130Cas localization 
to nascent adhesive sites in migrating cells 
thereby leading to the activation of the small 
GTPase Rac, whereas Zyxin interacts with the 
SH3 domain of p130Cas and with a nucleocyto-
plasmic transcription factor, CIZ/NMP4/ZNF384 
[47]. 
 
Recent data also show that p130Cas activates 
several GTPases other than Rac. The associa-
tion between p130Cas and AND-34, an NSP 
family member, which acts as a GTP exchange 
factor for Ral, Rap1 and R-Ras enhances Src 
activation and cell migration, likely through a 
Rap1-dependent mechanism [48].  
 
p130Cas and cell invasion 
 
p130Cas tyrosine phosphorylation upon integrin 
or growth factor receptor activation has also 
been linked to cell invasion and it has been re-
Figure 4. p140Cap impairs EGF-dependent cell scatter through inhibition of Src activity. Adherens junction dynamics 
are important for cell scatter. p140Cap by increasing the amount of immobilized E-cadherin at the cell surface, regu-
lates the ability of cells to scatter. Left panels: p140Cap over-expressing (p140-oe) and Ctr breast cancer MCF-7 cells 
infected with GFP or kinase-negative Csk mutant (Csk-KD) recombinant adenoviruses were grown in small islets, se-
rum deprived for 12 h, untreated (a,d) or treated with 50ng/ml EGF for 12 h (b, c, e, and f), fixed, stained with Diff 
Quick kit, and photographed at 20x magnification (bar is 10 mm). Right panel: the mean area of the colonies was 
measured with Metamorph software in 20 random fields on six independent experiments (*p<0.05). The data show 
that p140Cap impairs the EGF-dependent cell scatter ability (panel e) and that the rescue of Src kinase activity is 
sufficient to restore cell scatter (panel f). The figure is modified from [31]. 
 p140Cap and p130Cas in cell migration and invasion 
 
 
669                                                                                                            Am J Cancer Res 2011;1(5):663-673 
ported that the SH3 domain of p130Cas is also 
required for this process. Indeed, Fak-null cells 
are not invasive when transformed by v-Src, but 
they acquire invasive properties upon over-
expression of p130Cas SH3 domain, indicating 
that this domain is required for rescue of v-Src 
cell invasion. In this context, the formation of 
Src/p130Cas/Crk/DOCK180 complex increases 
Rac1 and JNK activities and MMP-9 expression, 
leading to an invasive cell phenotype [49].  
 
Another effector that associates to p130Cas 
SH3 domain and mediates invasion is CIZ (Cas-
Interacting Zinc finger protein). This nucleocyto-
plasmic shuttling protein, by binding to a con-
sensus-like sequence in the matrix metallo pro-
teinase (MMPs) promoter, up-regulates the tran-
scription of MMPs [50], thus acting as a down-
stream element connecting p130Cas to the 
invasive program. Negative regulators of cell 
invasion have also been shown to impact on 
p130Cas. One of this is p140Cap which when 
over-expressed in breast carcinoma cells inhib-
its Src kinase activity resulting in down-
regulation of p130Cas tyrosine phosphorylation 
and consistently of cell invasion [31]. In addi-
tion, the KAI1/CD82 protein, a member of the 
tetraspanin superfamily, has been recently re-
discovered as a cancer metastasis suppressor 
and suppresses prostate carcinoma cell migra-
tion by decreasing p130Cas protein levels and 
its coupling with Crk [51, 52]. 
 
In breast carcinoma cells, the ErbB2 oncogene 
potentiates the migration and invasion machin-
ery facilitating p130Cas/Crk coupling and ERK 
activation [53]. Recently, we have reported that 
in p130Cas null MEFs transformed by ErbB2, 
the absence of p130Cas result in the inability to 
migrate and invade, that is rescued by re-
expression of full lenght p130Cas [54]. More-
over, p130Cas silencing in ErbB2-dependent 
breast carcinoma impairs in vitro migration and 
invasion as well as in vivo lung metastasis for-
mation. The human mammary MCF10A.B2 cells 
that express a chimeric form of ErbB2, which 
can homodimerise in the presence of the syn-
thetic ligand AP1510 [55], are a suitable in vitro 
model for the study of the ErbB2-dependent 
transformation in three-dimensional (3D) matrix 
instead of the classical monolayer culture. Inter-
estingly, p130Cas over-expression in 
MCF10A.B2 cells confers 3D invasive capacity 
to the acinar structures with degradation of the 
basement membrane and the formation of 3D 
matrix adhesions (Figure 5). The 3D invasion of 
p130Cas over-expressing (Figure 6)/ErbB2 
transformed epithelial cells is dependent on 
activation of both Erk1/2 MAPK and PI3K Akt 
signaling pathways with subsequent hyper acti-
vation of mTOR/p70S6K and Rac1, as two dis-




As outlined in this review, p140Cap and 
p130Cas adaptor proteins represent key ele-
ments in the control of cell migration and inva-
sion in normal and pathological conditions. 
Their expression pattern in tissues and cells do 
not completely overlaps, since, while p130Cas 
is ubiquitous, p140Cap is preferentially ex-
pressed in neurons and in epithelial cells. In 
breast cancers, p130Cas is frequently over-
expressed, while p140Cap is not expressed in 
more aggressive human breast cancers [56]. 
Interestingly, Src kinase is a common target of 
these two proteins. Even though both p130Cas 
and p140Cap have been described to bind to 
Src, they exert opposite roles on Src activity. 
Indeed p140Cap is a negative regulator of Src 
kinase, while p130Cas enhances and sustains 
Src activity. Therefore, it is likely that Src activity 
is finely tuned by p140Cap and p130Cas rela-
tive expression in tissues in which they are co-
expressed. Interestingly, their reciprocal levels 
Figure 5. p130Cas triggers acina invasion of ErbB2 
transformed MCF10 cells. p130Cas over-expressing 
or Mock ErbB2 transformed MCF10 cells were plated 
on a Matrigel/collagen 1:1 matrix and left un-
stimulated or activated for ErbB2 by treating with the 
small molecule AP1510. 3D invasive protrusions are 
present only in p130Cas over-expressing and ErbB2 
activated acinar structures. The figure is modified 
from [57]. 
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Figure 6. 3D matrix adhesions in invasive acinar structures of ErbB2 transformed MCF10 cells over-expressing 
p130Cas. p130Cas over-expressing ErbB2 transformed MCF10 cells were plated on a Matrigel/collagen 1:1 matrix 
and activated for ErbB2. Confocal images representing 3D matrix adhesions characterizing invasive protrusions of 
p130Cas over-expressing and ErbB2-activated acini. F-actin (purple, panel a), beta-1 integrin (red, panel b) and fi-
bronectin (green, panel c) staining are shown together with merged images (panel d). Magnifications of the insets are 
shown in panels e, f, g and h. White arrows in panel h indicate co-localization between beta1 integrin and fibronectin. 
Scale bars: 25 μm. The figure is modified from [57]. 
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of expression might influence the ability of can-
cer cells to migrate and to invade. Therefore, in 
a next future it would be very important to 
evaluate how the balance between these two 
proteins results in different degrees of cell mi-
gration and invasion during normal develop-
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